The abstract is read at the publisher; the summary is JClub's.
Human retinal organoid transplantation at the optic nerve crush site in C57 mice preserves retinal structure and improves visual-pathway function, with flash VEP P2 amplitude higher at all time points.
- Why it matters: Traumatic optic nerve injury can cause lasting visual disability, and there is no therapy that both protects retinal neurons and restores visual-pathway activity.
- What they did: Embryonic stem cell–derived human retinal organoids were transplanted at day 30 after optic nerve crush, then assessed across post-surgical days 7, 14, and 28 using immunostaining, microelectrode-array activity, ERG, flash VEP, optomotor testing, and light-dark behavior.
- The result: Transplantation preserved optic-disc appearance and ganglion cell layer thickness (distinguishable from crush-only at day 28), attenuated RBPMS/TUJ1 loss with altered IBA1 responses, showed no ERG b-wave differences, and increased VEP P2, optomotor responses, and dark-compartment occupancy.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.